Dosidal · Switzerland

REVLIMID, Hartkapseln

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:57712 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 57712
atc: L04AX04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2007-08-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L04AX04
authorisation_number: 57712
form: KAHA
holder: Bristol-Myers Squibb SA
holder_partner_nr: 1100488
it_number: 07.16.4.
name: REVLIMID, Hartkapseln
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
eMdJR_UguVPaC3SG-Y0qHeOnwdhU8uP9G3Rg6KHDAoHRGrfexp5Uujr4QIc0En4dTFffp__GCcinp-8108Y4Qw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:57712 · Same medicine in other markets · Dosidal